CLUHP6

Across TCGA pan-cancer cohorts, CLUHP6 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated CLUHP6 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher CLUHP6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CLUHP6 expression acts as an unfavorable survival marker, although some lineages such as BLCA and KIRP show a favorable association.

MESO, KICH, and CHOL are the cancer types where CLUHP6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	III,IV	0.084	0.387	<.001	90	view →
KICH	DFS	Tertile	All	0.613	0.906	.003	73	view →
CHOL	DFS	Tertile	All	0.250	0.544	.028	27	view →
ACC	DFS	Tertile	II,III,IV	0.120	0.532	.012	18	view →
BLCA	OS	Tertile	II,III,IV	0.775	0.681	.021	16	view →
KIRP	OS	Tertile	II,III,IV	0.925	0.755	.019	16	view →
SARC	OS	Tertile	All	0.262	0.548	.002	15	view →
ESCA	OS	Tertile	IV	0.864	0.219	.024	12	view →
UCEC	DFS	Tertile	IV	0.884	0.571	.025	12	view →
READ	OS	Tertile	All	0.829	0.954	.022	9	view →
OV	OS	Quartile	IV	0.563	0.813	.031	4	view →
LGG	OS	Tertile	All	0.771	0.348	.001	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

CLUHP6–MESO (DFS)

Open the MESO breakdown →